Efficacy and safety of oral immunotherapy in children aged 1–3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study is a research paper published in UNC Libraries (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5UM2AI117870-03
Rho Federal Systems Division, Inc. NIAID DAIT SACCC
National Institutes of Health
Grant: 3UM1AI109565-09S1
Immune Tolerance Network
FWCI
0.00
Citation Percentile
0.0%
Fields of Study
Keywords
Sustainable Development Goals